Sponsor:
Paul Szabolcs
Code:
NCT03500731
Conditions
Idiopathic Pulmonary Fibrosis
Emphysema or COPD
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
CD3/CD19 negative hematopoietic stem cells
Rituximab
Alemtuzumab
Fludarabine
Thiotepa
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-17. This information was provided to ClinicalTrials.gov by Paul Szabolcs on 2025-01-09.